22nd Century Group Cuts $1.5M Debt, Extends Loan Balance by Mark Eisenberg 26.06.2024 22nd Century Group cuts debt by $1.5M, aiming for financial stability and progress in tobacco harm reduction using advanced technology.
Philip Morris Halts Zyn.com Sales After D.C. Subpoena by Mark Eisenberg 18.06.2024 Philip Morris halts nationwide ZYN.com sales amid D.C. subpoena on flavored nicotine pouches. Investigation on compliance with 2022 flavor ban ...
Investing in Philip Morris International: A Smoking-Hot Buy by Terry Bingman 31.03.2024 Global tobacco giant, Philip Morris International, has struggled in recent years but holds potential for growth with its IQOS and ...
22nd Century Group, Inc.: Financial Report Reveals Industry Challenges by Terry Bingman 28.03.2024 22nd Century Group, Inc. (XXII): A promising tobacco industry player with innovative plant science focus, solid financials & growth potential. ...
Incannex’s Breakthrough Chewing Gum Aids Smoking Cessation by Mark Eisenberg 16.02.2024 Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
22nd Century Group Slashes Board Pay, Eyes $1M Savings by Mark Eisenberg 14.02.2024 22nd Century Group, Inc. (NASDAQ: XXII) announces major cost cuts in board compensation, aiming to save over $1 million annually ...